| ID | Age | Sex | State | Date ▼ | Onset Days | Vaccine | Manufacturer | Lot # | Symptoms | Narrative | 💀 | 🏥 | 🚑 | ♿ | ⚠️ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2859682 | 32 | M | TX | 09/18/2025 |
FLU3 |
GLAXOSMITHKLINE BIOLOGICALS |
B59DH |
Device delivery system issue, Immediate post-injection reaction, Injection site ...
Device delivery system issue, Immediate post-injection reaction, Injection site haematoma
More
|
Hematoma formation immediately after injection with blood backflow in syringe. No aspiration perform...
Hematoma formation immediately after injection with blood backflow in syringe. No aspiration performed per immunization administration standards. Pressure applied, bandage placed, no other adverse reactions noted. Patient did note has gotten larger flu shot localized reactions previously. Only with flu shots.
More
|
||||||
| 2859683 | 65 | F | ID | 09/18/2025 |
FLU3 |
SANOFI PASTEUR |
U8800BA |
Injection site erythema, Injection site induration, Injection site inflammation,...
Injection site erythema, Injection site induration, Injection site inflammation, Injection site warmth
More
|
Pt came back to pharmacy on 9/15, reporting large red area around injection site. Site was hot and f...
Pt came back to pharmacy on 9/15, reporting large red area around injection site. Site was hot and firm to the touch. No attempts had been made to decrease inflammation (Benadryl, icepack...). recommended to pt to try both options, and to come back if there was no decrease, or of there was worsening symptoms. Pt has not reported back .
More
|
||||||
| 2859684 | 65 | M | WI | 09/18/2025 |
FLU3 |
SANOFI PASTEUR |
U8800DA |
Throat tightness
Throat tightness
|
Patient states that he woke up morning after vaccine and throat felt like it was closing
Patient states that he woke up morning after vaccine and throat felt like it was closing
|
||||||
| 2859685 | 7 | M | WA | 09/18/2025 |
DTAP |
SANOFI PASTEUR |
|
No adverse event, Product administered to patient of inappropriate age
No adverse event, Product administered to patient of inappropriate age
|
Daptacel given in error, patient is a year older than age range. NO adverse effects reported by par...
Daptacel given in error, patient is a year older than age range. NO adverse effects reported by parent, and revaccination not recommended by manufacturer.
More
|
||||||
| 2859686 | 55 | F | 09/18/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
3t74x |
Extra dose administered
Extra dose administered
|
duplicate vaccine--we administered a 3rd unnecessary dose
duplicate vaccine--we administered a 3rd unnecessary dose
|
|||||||
| 2859687 | 80 | F | SC | 09/18/2025 |
FLU3 HEP PNC21 |
SANOFI PASTEUR DYNAVAX TECHNOLOGIES CORPORATION MERCK & CO. INC. |
u8859ba 946908 z003579 |
Arthralgia, Neck pain, Urticaria; Arthralgia, Neck pain, Urticaria; Arthralgia, ...
Arthralgia, Neck pain, Urticaria; Arthralgia, Neck pain, Urticaria; Arthralgia, Neck pain, Urticaria
More
|
patient woke up the day after the vaccine with pain in her neck and shoulder on the left side...2 da...
patient woke up the day after the vaccine with pain in her neck and shoulder on the left side...2 days later she developed hives
More
|
||||||
| 2859688 | 37 | M | FL | 09/18/2025 |
COVID19 COVID19 |
JANSSEN PFIZER\BIONTECH |
|
Condition aggravated, Depression, Hypertension; Condition aggravated, Depression...
Condition aggravated, Depression, Hypertension; Condition aggravated, Depression, Hypertension
More
|
Depression anxiety high blood pressure
Depression anxiety high blood pressure
|
||||||
| 2859689 | 1.58 | M | CA | 09/18/2025 |
PNC15 VARCEL |
MERCK & CO. INC. MERCK & CO. INC. |
Z005994 Z004246 |
Extra dose administered, No adverse event; Extra dose administered, No adverse e...
Extra dose administered, No adverse event; Extra dose administered, No adverse event
More
|
The patient did not experience any adverse reactions. It was realized today as patient received his ...
The patient did not experience any adverse reactions. It was realized today as patient received his vaccine that it was given in error and that he already did receive the fourth pneumococcal vaccine. The fourth dose was not transcribed into the chart. Also it was discovered today on a more detailed review of his records that the child did receive a varicella vaccine in error as well on a different date-given 8/21/2025.
More
|
||||||
| 2859690 | 38 | M | TN | 09/18/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Infertility male, Palpitations
Infertility male, Palpitations
|
Heart palpitations, fertility issues
Heart palpitations, fertility issues
|
✓ | |||||
| 2859691 | 60 | M | MI | 09/18/2025 |
FLU3 |
GLAXOSMITHKLINE BIOLOGICALS |
5554G |
Expired product administered
Expired product administered
|
Patient given expired Influenza vaccination. Notified pharmacy. from drug information centerAccord...
Patient given expired Influenza vaccination. Notified pharmacy. from drug information centerAccording to the CDC, the Vaccine Adverse Event Reporting System (VAERS) has noted that receiving expired flu vaccine does not pose additional risks for adverse events beyond those of appropriately dated vaccine. However, the potency of the vaccine may decline with time. Their recommendation is that any person who receives an expired influenza vaccine should be revaccinated with the current season?s influenza vaccine. Please be sure to remove any other expired vaccines from stock to prevent additional errors, and file an RL at your earliest convenience if not already reported.
More
|
||||||
| 2859692 | 17 | F | MT | 09/18/2025 |
MENB |
NOVARTIS VACCINES AND DIAGNOSTICS |
G334J |
Injection site erythema, Local reaction
Injection site erythema, Local reaction
|
Local Reaction, redness around injection site
Local Reaction, redness around injection site
|
||||||
| 2859693 | 28 | M | TX | 09/18/2025 |
COVID19 |
JANSSEN |
|
Atrial fibrillation, Cardiac ablation, Laboratory test, Pulmonary vein stenosis
Atrial fibrillation, Cardiac ablation, Laboratory test, Pulmonary vein stenosis
|
I was diagnosed and treated for atrial fibrillation at emergency room. Further tests confirmed the ...
I was diagnosed and treated for atrial fibrillation at emergency room. Further tests confirmed the condition. In 2023 I had a heart ablation done at Medical Center. After the heart ablation, I was diagnosed with pulmonary vein stenosis.
More
|
✓ | |||||
| 2859694 | 72 | F | CA | 09/18/2025 |
COVID19 |
MODERNA |
3052549 |
Blood blister, Contusion, Immediate post-injection reaction, Mouth haemorrhage, ...
Blood blister, Contusion, Immediate post-injection reaction, Mouth haemorrhage, Stomatitis
More
|
PATIENT HAD BIG BRUISES ALL OVER THE BODY, SAID GOT SORES RIGHT AFTER VACCINATION IN HER MOUTH AND W...
PATIENT HAD BIG BRUISES ALL OVER THE BODY, SAID GOT SORES RIGHT AFTER VACCINATION IN HER MOUTH AND WHICH BURSTED AND NOW BLEEDING INSIDE MOUTH AND BLOOD CLOT ON LIPS
More
|
||||||
| 2859695 | 44 | M | WA | 09/18/2025 |
FLU3 |
SEQIRUS, INC. |
948401 |
Dizziness, Nausea
Dizziness, Nausea
|
Nausea and dizziness all day
Nausea and dizziness all day
|
||||||
| 2859696 | 11 | F | AL | 09/18/2025 |
HPV9 |
MERCK & CO. INC. |
YO15760 |
Fall, Pallor
Fall, Pallor
|
After receiving HPV vaccine pt fell back on to bed. No noted loss of consciousness. Pt was skin colo...
After receiving HPV vaccine pt fell back on to bed. No noted loss of consciousness. Pt was skin color was pale. Pt was assisted up in a sitting position and given sips of water. Pt Vitals was checked noted to be WNL. Patient was observed for 20 min and was sent home. Parent advised to RTC if other symptoms arise....RN
More
|
||||||
| 2859697 | 7 | F | VT | 09/18/2025 |
DTAP |
SANOFI PASTEUR |
3CA11C1 |
No adverse event, Product administered to patient of inappropriate age
No adverse event, Product administered to patient of inappropriate age
|
No reaction
No reaction
|
||||||
| 2859698 | 21 | M | GA | 09/18/2025 |
COVID19 |
JANSSEN |
|
Dyspnoea, Heart rate increased, Influenza like illness
Dyspnoea, Heart rate increased, Influenza like illness
|
After shot I felt as though I got the flu. Ever since I?ve had shortness of breath and elevated hear...
After shot I felt as though I got the flu. Ever since I?ve had shortness of breath and elevated heart rate from simple exercises.
More
|
||||||
| 2859699 | 12 | F | MT | 09/18/2025 |
HPV9 HPV9 MNQ MNQ TDAP TDAP |
MERCK & CO. INC. MERCK & CO. INC. NOVARTIS VACCINES AND DIAGNOSTICS NOVARTIS VACCINES AND DIAGNOSTICS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
Z007396 Z007396 3E99M 3E99M M77CC M77CC |
Anxiety, Hyperventilation, Hypoaesthesia, Pain in extremity, Panic attack; Parae...
Anxiety, Hyperventilation, Hypoaesthesia, Pain in extremity, Panic attack; Paraesthesia, Pharyngeal swelling, Stridor; Anxiety, Hyperventilation, Hypoaesthesia, Pain in extremity, Panic attack; Paraesthesia, Pharyngeal swelling, Stridor; Anxiety, Hyperventilation, Hypoaesthesia, Pain in extremity, Panic attack; Paraesthesia, Pharyngeal swelling, Stridor
More
|
Pt receiving vaccines during provider visit on this day. During well child visit/establishing care ...
Pt receiving vaccines during provider visit on this day. During well child visit/establishing care appointment, dad reports patient allergies to bee stings/mosquito bites and pt uses epi-pen for reactions. Pt given 12 year old vaccines: Tdap, Men4, and HPV. Dad reports NKA. Vaccines given at 1635 back to back with RN on one side of patient. Roughly 1 minute after receiving HPV vaccine pt reports arm hurting so RN left room to get cold pack. Pt then started hyperventilating stating she was feeling tingly, so this writter yelled down the hall for RN to get pcp NP. O2 was given starting at 2 liters, while PCP gave verbal order for Methylprednisone 125mg injection to be given. Dr called 911 for ambulance. Methylprednisone 125mg was injected into Left arm at 1640. Vital signs were taken during this time. BP 114/71, HR 117. Patient was reporting feelings of numbness in face going down into arms, swelling in throat, and presented with small amounts of stridor during breaths. Fire truck and ambulance appeared to clinic around 1648 to do full assessment on patient. After assessing patient Paramedic determined that it was not an anaphylactic reaction and thought to be more of an anxiety/panic attack from vaccines. Gave parent of patient option to decide if he wanted pt to go to ER for further evaluation. Father denied trip to ER, EMS left, and patient reported feeling better at this time which was 1705. Pt was wheel chaired out of the facility to transportation. Advised dad to keep close eye on pt for remainder of the day. If pt began to experience difficulty breathing or felt like throat was swelling at home, report to ER. Dad states understanding. No other concerns.
More
|
||||||
| 2859700 | 21 | M | CA | 09/18/2025 |
COVID19 |
PFIZER\BIONTECH |
EL 1283 |
Asthma, Dyspnoea, Magnetic resonance imaging thoracic abnormal, Pneumonia
Asthma, Dyspnoea, Magnetic resonance imaging thoracic abnormal, Pneumonia
|
Contraction or Asthma, continual shortness of breath, pneumonia
Contraction or Asthma, continual shortness of breath, pneumonia
|
||||||
| 2859701 | 65 | F | NC | 09/18/2025 |
COVID19 FLU3 |
MODERNA SEQIRUS, INC. |
3052030 407257 |
Anaphylaxis treatment, Dyspnoea, Loss of consciousness, Resuscitation; Anaphylax...
Anaphylaxis treatment, Dyspnoea, Loss of consciousness, Resuscitation; Anaphylaxis treatment, Dyspnoea, Loss of consciousness, Resuscitation
More
|
Patient after leaving the immunization room, came back and told the pharmacist that they could not b...
Patient after leaving the immunization room, came back and told the pharmacist that they could not breathe. As soon as the patient sat down per the pharmacist's instructions the patient passed out. The pharmacist administered epinephrine and started chest compressions.
More
|
||||||
| 2859702 | 53 | F | MO | 09/18/2025 |
VARZOS VARZOS |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
NR4T5 NR4T5 |
Axillary mass, Erythema, Haemorrhage, Immediate post-injection reaction, Indurat...
Axillary mass, Erythema, Haemorrhage, Immediate post-injection reaction, Induration; Injection site pain, Pain in extremity, Pyrexia
More
|
Bleeding immediately after vaccine (administered Thursday morning), redness, arm sore, and 103 fever...
Bleeding immediately after vaccine (administered Thursday morning), redness, arm sore, and 103 fever within a few hours of injection . Patient went to Dr on Tuesday had appointment scheduled and was prescribed 10 day course of Keflex 500 q6h-patient states Dr. said lump under arm and surrounding area felt hard like a turtle shell - treatment took care of issues- patient still today has tenderness at injection site but lump is gone
More
|
||||||
| 2859703 | 3 | F | NY | 09/18/2025 |
MMR |
MERCK & CO. INC. |
|
Agitation, Discomfort, Pruritus, Urticaria
Agitation, Discomfort, Pruritus, Urticaria
|
Patient developed a widespread outbreak of hives, beginning at her chin and extending down to her hi...
Patient developed a widespread outbreak of hives, beginning at her chin and extending down to her hips, affecting her stomach and back. She was extremely itchy, uncomfortable, and highly agitated, which prompted us to take her to the doctor for evaluation. The physician explained that it is not possible to confirm with certainty whether the reaction was caused by the MMR vaccine. However, patient had no unusual exposures that day?she consumed her typical foods and had no contact with new products or allergens. The only new factor was the MMR vaccine, which she received within the timeframe during which the doctor noted a reaction could potentially occur.
More
|
||||||
| 2859704 | 84 | M | GA | 09/18/2025 |
UNK |
UNKNOWN MANUFACTURER |
|
Pain in extremity
Pain in extremity
|
Vaccination in left arm. Next day pain in right thigh
Vaccination in left arm. Next day pain in right thigh
|
||||||
| 2859705 | 4 | F | WA | 09/18/2025 |
CHIK MMRV |
BAVARIAN NORDIC MERCK & CO. INC. |
U8209CB Z008222 |
Erythema, Skin warm, Swelling, Tenderness, Wound; Erythema, Skin warm, Swelling,...
Erythema, Skin warm, Swelling, Tenderness, Wound; Erythema, Skin warm, Swelling, Tenderness, Wound
More
|
Redness, swelling, Hot to touch 5x5cm round erythematous. Puncture wound in the middle. Tender...
Redness, swelling, Hot to touch 5x5cm round erythematous. Puncture wound in the middle. Tender to palpation
More
|
||||||
| 2859706 | 65 | F | FL | 09/18/2025 |
PNC20 |
PFIZER\WYETH |
MA2502 |
Injection site swelling
Injection site swelling
|
Patient presented to pharmacy on 9/18/25 complaining of swollen injection site
Patient presented to pharmacy on 9/18/25 complaining of swollen injection site
|
||||||
| 2859707 | 0.33 | F | MI | 09/18/2025 |
DTPPVHBHPB |
MSP VACCINE COMPANY |
u7829aa |
Extra dose administered, No adverse event, Wrong product administered
Extra dose administered, No adverse event, Wrong product administered
|
Vaxelis was given and the vaccine that was supposed to be given was Pentacel instead. Patient ended ...
Vaxelis was given and the vaccine that was supposed to be given was Pentacel instead. Patient ended up with an extra hepatitis B due to this error. There was no adverse event reported. Staff noticed the error at the end of the day. Provider was notified and no treatment was needed.
More
|
||||||
| 2859708 | 31 | M | TN | 09/18/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Cardiovascular symptom, Impaired driving ability
Cardiovascular symptom, Impaired driving ability
|
Following my second dose of the COVID-19 vaccine, while driving to work I began experiencing symptom...
Following my second dose of the COVID-19 vaccine, while driving to work I began experiencing symptoms that made me feel as though I was having a heart attack. I had to pull over and call an ambulance. I was evaluated and released with instructions to follow up with my doctor and/or the emergency department
More
|
||||||
| 2859709 | 32 | M | TX | 09/18/2025 |
COVID19 COVID19 COVID19 |
JANSSEN JANSSEN JANSSEN |
1805020 1805020 1805020 |
Dyspnoea, Heart rate increased, Impaired work ability, Inflammation, Laboratory ...
Dyspnoea, Heart rate increased, Impaired work ability, Inflammation, Laboratory test; Mobility decreased, Multisystem inflammatory syndrome, Pain, Respiratory disorder, Respiratory tract infection; Sinusitis, Supraventricular tachycardia, Tinnitus, Upper respiratory tract infection
More
|
On January 1st 2022, I got a severe respiratory infection and since then have had some form of sinus...
On January 1st 2022, I got a severe respiratory infection and since then have had some form of sinus or upper respiratory infection at least once every 90 days for the last 3 1/2 years. On May 26, 2024 I was admitted to the ER due to a Supraventricular Tachycardia. I was subsequently out of work for 2+ months due to inflammation that would change locations daily and was so painful that I spent the majority of time in bed. I was seen by Cardiology and Rheumatology over the course of the next year and a diagnosis or reason could not be determined. Though no diagnosis has been made, I still suffer from shortness of breath, tinitus of both ears, a higher resting heart rate than previously and random bouts of multisystem inflammation and respiratory illness.
More
|
✓ | |||||
| 2859710 | 29 | F | NC | 09/18/2025 |
COVID19 COVID19 FLU3 FLU3 |
MODERNA MODERNA SEQIRUS, INC. SEQIRUS, INC. |
3052550 3052550 407000 407000 |
Asthenia, Dizziness, Hyperhidrosis, Nausea, Syncope; Vertigo; Asthenia, Dizzines...
Asthenia, Dizziness, Hyperhidrosis, Nausea, Syncope; Vertigo; Asthenia, Dizziness, Hyperhidrosis, Nausea, Syncope; Vertigo
More
|
3 minutes after receiving injections, I started feeling nauseous. Within a few more seconds felt diz...
3 minutes after receiving injections, I started feeling nauseous. Within a few more seconds felt dizzy. Grabbed onto something and then fainted. During the fainting, everything was spinning around and I felt extremely weak. I didn?t fall or black out completely but I definitely fainted and would have fallen if I hadn?t grabbed onto something. After a minute of this fainting spell, I slowly went to a chair and sat for another few minutes. My body was all sweaty. Within a few more minutes I felt fine enough to drive home.
More
|
||||||
| 2859711 | 86 | F | MT | 09/18/2025 |
RSV RSV |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
5h777 5h777 |
Chills, Erythema, Injection site erythema, Injection site swelling, Limb discomf...
Chills, Erythema, Injection site erythema, Injection site swelling, Limb discomfort; Peripheral swelling, Pyrexia
More
|
Patient received the RSV vaccination on Monday 9/15 and didn't notice any issues. She stated on...
Patient received the RSV vaccination on Monday 9/15 and didn't notice any issues. She stated on Tuesday 9/16 she had common side effects such as fever and chills. Then Wednesday 9/17 she reported that her whole right arm was swollen and red from the injection site down and is still that way after 24 hours. Patient stated it does not hurt it is just uncomfortable and seemed to be in okay spirits.
More
|
||||||
| 2859712 | 78 | F | WA | 09/18/2025 |
RSV |
PFIZER\WYETH |
LG9828 |
Injection site erythema, Injection site nodule
Injection site erythema, Injection site nodule
|
Erythematous Nodule 2-3mm in diameter on left upper mid lateral arm. Not in the same spot as the inj...
Erythematous Nodule 2-3mm in diameter on left upper mid lateral arm. Not in the same spot as the injection was given.
More
|
||||||
| 2859713 | 28 | F | NE | 09/18/2025 |
TDAP |
GLAXOSMITHKLINE BIOLOGICALS |
H4K3S |
Anaphylaxis treatment, Endotracheal intubation, Rash, Somnolence
Anaphylaxis treatment, Endotracheal intubation, Rash, Somnolence
|
Tdap given at 1041, symptoms of rash to chest started around 1050. 911 called. Epipen given. Oxygen ...
Tdap given at 1041, symptoms of rash to chest started around 1050. 911 called. Epipen given. Oxygen applied. Patient began to be more sleepy, second dose of Epipen given. Patient was taken to outside hospital by EMS. From limited view of outside hospital medication records, patient required intubation at outside hospital related to reaction.
More
|
✓ | ✓ | ||||
| 2859714 | 28 | M | VA | 09/18/2025 |
COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH |
EN6199 EN6199 |
Biopsy skin abnormal, Dermatitis atopic, Eczema, Emotional distress, Phototherap...
Biopsy skin abnormal, Dermatitis atopic, Eczema, Emotional distress, Phototherapy; Quality of life decreased, Rash
More
|
I broke out with a rash within days of receiving the first shot and it became uncontrollable. I was ...
I broke out with a rash within days of receiving the first shot and it became uncontrollable. I was first seen for medical help on 3/24/21 and eventually was elevated up to see a dermatologist regularly. I was forced to receive the second dose of Pfizer on 3/25/21 and the lot# was ER8730. I have been on multiple biologics, oral and subcutaneous steroids, phototherapy, and the latest being JAK inhibitors. It has been nonstop since the first shot and has cost me much of my quality of life and destroyed my mental health.
More
|
✓ | |||||
| 2859715 | 40 | M | AL | 09/18/2025 |
COVID19 COVID19 COVID19 |
JANSSEN JANSSEN JANSSEN |
1855191 1855191 1855191 |
Adverse drug reaction, Biopsy skin abnormal, COVID-19, Chest pain, Contusion; Im...
Adverse drug reaction, Biopsy skin abnormal, COVID-19, Chest pain, Contusion; Immune system disorder, Impaired work ability, Rash, Rash macular, Skin discolouration; Tenderness
More
|
Rash with tiny red spots that began inner thighs, then spread out over entire body until everything ...
Rash with tiny red spots that began inner thighs, then spread out over entire body until everything but the face was covered over roughly 4 week period of time. Rash looked like mini sized chickenpox, just much closer together red bumps with discoloration of the skin even looking purple and bruised in large areas. (Photos are available). PCM continued to brush off, accuse of taking something that was causing a reaction yet no other medications or supplements had been taken other than vaccinations given. Healthy otherwise on vegetarian diet, non-smoker, non-drinker, no supplements or medications whatsoever. Even careful not to eat poppy seed food items. Was recommended by PCM cortisone cream, motrin, and prescriptions from the doctor that did not do anything to give relief. After multiple non-productive visits to the PCM, was sent to see dermatologist and she did a biopsy in 2 areas, sent out that came back confirming "drug reaction". Lasted total time roughly 4-6 weeks start to finish visibly. Never got actual help, just brushed off even after confirmed drug reaction was confirmed from the biopsy. Ended up having to be off work as it was painful to the touch, clothing was very uncomfortable. Could not work out, could not do everyday activities, did not go into work. Missed 4x as much work from this vaccine reaction than was lost from being sick with covid itself over christmas.
More
|
||||||
| 2859716 | 66 | F | CA | 09/18/2025 |
FLU3 |
SANOFI PASTEUR |
U8855AA |
Anaphylactic reaction, Dyspnoea, Pharyngeal swelling
Anaphylactic reaction, Dyspnoea, Pharyngeal swelling
|
Anaphylactic reaction. Could not breathe, throat swelling.
Anaphylactic reaction. Could not breathe, throat swelling.
|
||||||
| 2859717 | 71 | F | ID | 09/18/2025 |
COVID19 FLU3 PNC21 |
PFIZER\BIONTECH SANOFI PASTEUR MERCK & CO. INC. |
MY9547 U8800BA Z006889 |
Injection site oedema, Injection site pain, Injection site rash; Injection site ...
Injection site oedema, Injection site pain, Injection site rash; Injection site oedema, Injection site pain, Injection site rash; Injection site oedema, Injection site pain, Injection site rash
More
|
Edema, rash, and pain starting just below the vaccine site to just above the elbow. Patient was inst...
Edema, rash, and pain starting just below the vaccine site to just above the elbow. Patient was instructed to ice the arm, take benadryl and zyrtec and if no improvement in 24 hours she was instructed to call her primary care provider or if worsening of symptoms to seek urgent medical treatment.
More
|
||||||
| 2859752 | F | SC | 09/18/2025 |
PNC21 |
MERCK & CO. INC. |
Z004301 |
Injection site reaction, Rash erythematous
Injection site reaction, Rash erythematous
|
Injection site erythema; Injection site rash; Information has been received from FDA (agency #284389...
Injection site erythema; Injection site rash; Information has been received from FDA (agency #2843894-1) and refers to a 69-year-old female patient. The patient's medical history included history of malignant neoplasm of breast. The patient's concurrent conditions included allergic rhinitis, cervical spondylosis, gastroesophageal reflux disease without esophagitis, hyperlipidemia, hypertension with disorder of left retina, hypertension with disorder of left retina, hypertensive heart disease without congestive heart failure, long-term drug therapy, neck pain, obese, class II osteopenia, polyp of nasal sinus, sleep apnea, vitamin D deficiency, and albuterol, lisinopril, Motrin allergy. Concomitant medications included Cephalexin (Cefalexin), Fluticasone propionate (Fluticasone propionate), Klor-con m10 (Potassium chloride), 2.5 mg Letrozole (Letrozole), Losartan potassium and hydrochlorothiazide (Hydrochlorothiazide;Losartan potassium), Metoprolol tartrate (Metoprolol tartrate), 10 mg Montelukast (Montelukast sodium), Potassium chloride (Potassium chloride), 10 mg Pravastatin (Pravastatin sodium), Tylenol (Paracetamol), 5000 IU Vitamin d3 (Colecalciferol), Zyrtec (Cetirizine hydrochloride) . On 27-May-2025, the patient started therapy with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) Solution for injection (lot #Z004301, expiration date: 07-Sep-2026), dose number 1, administered by Intramuscular route in Left Arm for an unknown indication. On 02-JUN-2025, the patient's entire upper left arm has a redness rash down to the elbow. On 03-Jun-2025, the patient experienced Injection site rash. On 03-Jun-2025, the patient experienced Injection site erythema. At the reporting time, the outcome of Injection site rash and Injection site erythema was unknown. The causal relationship between the event of injection site erythema and injection site rash and Pneumococcal 21-valent Conjugate Vaccine was not provided.
More
|
|||||||
| 2859753 | MA | 09/18/2025 |
HPV4 HPV9 |
MERCK & CO. INC. MERCK & CO. INC. |
|
Circumstance or information capable of leading to medication error, Inappropriat...
Circumstance or information capable of leading to medication error, Inappropriate schedule of product administration, No adverse event; Circumstance or information capable of leading to medication error, Inappropriate schedule of product administration, No adverse event
More
|
no adverse event; inappropriate schedule of vaccine administration; in May 2024, I received my first...
no adverse event; inappropriate schedule of vaccine administration; in May 2024, I received my first dose of Gardasil 4. Due to personal circumstances, I was unable to follow the recommended schedule. On August 26, 2025, I received a dose of Gardasil 9; This spontaneous report was received from a consumer patient of unknown age and gender and refers to themself. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. In May 2024, the patient was vaccinated with the first dose of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL), Suspension for injection, dose number 1, (indication, expiration date, and lot # were not reported). Due to personal circumstances, the patient was unable to follow the recommended schedule. On 26-Aug-2025, the patient received second dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL�9) (interchange of vaccine products; inappropriate schedule of vaccine administration), Suspension for injection, dose number 2, (indication, expiration date, and lot # were not reported). The patient asked for advice how to proceed. Should one additional dose be received in 6 months to complete the series, or, since the initial Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL) dose was more than one year ago, should the patient restart a full 3-dose Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL�9) schedule beginning from today? No adverse event was reported.
More
|
||||||||
| 2859754 | 17 | F | TX | 09/18/2025 |
HPV9 |
MERCK & CO. INC. |
Y015179 |
No adverse event, Product storage error
No adverse event, Product storage error
|
patient did not experience any adverse issues or reactions from the administered vaccine and no othe...
patient did not experience any adverse issues or reactions from the administered vaccine and no other information was able to be provided; TE for GARDASIL 9 that took place on 07/08/2025 as well as 08/20/2025 and was inadvertently administered on 08/21/2025; This spontaneous report was received from a medical assistant and refers to a 17-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 07-Aug-2025 and on 20-Aug-2025, temperature excursion for Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL�9) took place was inadvertently administered on 21-Aug-2025, when the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL�9), (lot #Y015179, expiration date: 28-Jan-2027) (0.5mL / once) for prophylaxis (improper storage of product in use). The patient did not experience any adverse issues or reactions from the administered vaccine and no other information was able to be provided (no adverse event).
More
|
||||||
| 2859755 | 10 | F | TX | 09/18/2025 |
HPV9 |
MERCK & CO. INC. |
Y015179 |
No adverse event, Product storage error
No adverse event, Product storage error
|
the patient did not experience any adverse issues or reactions from the administered vaccine; a TE f...
the patient did not experience any adverse issues or reactions from the administered vaccine; a TE for GARDASIL 9 that took place on 07/08/2025 as well as 08/20/2025 and was inadvertently administered on 08/25/2025.; This spontaneous report was received from a medical assistant and refers to a 10-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 08-JUL-2025, human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) lot #Y015179 underwent temperature excursion (47.3 F for 50 minutes 20 seconds). On 20-AUG-2025, the vaccine underwent another temperature excursion (46.4 F for 25 minutes 50 seconds). On 25-AUG-2025, the patient was inadvertently vaccinated with improperly stored human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) suspension for injection at a total dose of 0.5 mL, lot #Y015179, expiration date: 28-JAN-2027, administered for prophylaxis (route of administration and anatomical location were not reported) (Product storage error). The patient did not experience any adverse issues or reactions from the administered vaccine. This is one of several reports received from the same reporter.
More
|
||||||
| 2859756 | 65 | M | CA | 09/18/2025 |
MEN UNK |
UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER |
U8493A A |
No adverse event, Product preparation error, Wrong product administered; No adve...
No adverse event, Product preparation error, Wrong product administered; No adverse event, Product preparation error, Wrong product administered
More
|
No adverse event; Was supposed to receive MMR instead using correct diluent, was reconstitued with M...
No adverse event; Was supposed to receive MMR instead using correct diluent, was reconstitued with Menquadfi; Wrong product administered; This spontaneous report was received from an Other-health professional and refers to a 65-year-old male patient. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were not reported. On 05-Aug-2025, the patient was vaccinated with a dose of Measles, Mumps, and Rubella (M-M-R) vaccine (manufacturer unknown) (lot #, expiration date, strength, dose number, anatomical location not provided); which was supposed to be reconstituted with sterile diluent; however, it was reconstituted with Meningococcal vaccine A/C/Y/W conj (tet tox) (MENQUADFI) Solution for injection (lot #U8493A A, expiration date: 31-May-2028) (wrong diluent used), and was administered intramuscular as prophylactic vaccination. The patient was not supposed to get Meningococcal vaccine A/C/Y/W conj (tet tox) (MENQUADFI) at all (wrong product administered). No reported adverse events.; Sender's Comments: Priority : 5 , Is case serious : No , Index user : Index date : 2025-09-03 , MNSC number : , CLIC number : , ESTAR number : , IRMS number : GS / 2025SA229864 , Central date : 2025-09-03 , Classification : DMC, Attachment description : Post Marketing Basic , Safety case number :
More
|
||||||
| 2859757 | 09/18/2025 |
HEP RV5 |
MERCK & CO. INC. MERCK & CO. INC. |
z004729 Z004726 |
No adverse event, Product lot number issue, Wrong product administered; No adver...
No adverse event, Product lot number issue, Wrong product administered; No adverse event, Product lot number issue, Wrong product administered
More
|
wrong vaccine; No additional AE; Product lot number issue; This spontaneous report has been received...
wrong vaccine; No additional AE; Product lot number issue; This spontaneous report has been received from a pharmacist, regarding to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, and previous drug reactions or allergies were not reported. On an unknown date, the patient was vaccine with Rotavirus Vaccine, Live, Oral, Pentavalent (Rotateq), (lot #Z004726, expiration date: 31-Oct-2026) or Hepatitis B Vaccine (Recombinant) (lot number z004729, expiration date) On an unknown date, the patient started therapy with Hepatitis B Vaccine (Recombinant) (lot #z004729) (expiration date ), both as prophylaxis, also it was reported a possible PQC, it was reported that lot #z004726 which was documented 70 times as administered doses for RECOMBIVAX HB, this agency placed the HCP on hold and caller with employee who stated lot# z004726 was associated with ROTATEQ and not RECOMBIVAX HB. The employee said he was unable to provide or confirm the NDC number for lot z004726 though so the NDC number was still unknown. The caller was informed the lot # z004726 was for ROTATEQ and the caller then provided additional details saying he had doses of RECOMBIVAX HB with the lot #z004729, but that he doesn't suspect this was user error as the lot #z004726. (Wrong product administered, Product lot number issue). No additional adverse events were reported in the patient. This case was determined to be non-valid due to the lack of patient identifiers.; Sender's Comments: Priority : 5 , Is case serious : No , number : 02864013-02863993 , number : , number : , number : 500UW00000k5Y55YAE|29082025170007|3316 , Central date : 2025-08-29 , Classification : , Attachment description : Call , Safety case number : , case number : 02864013 , interaction number : 02863993 , Integration log UniqueID : 500UW00000k5Y55YAE|29082025170007|3316 , Service cloud CaseID : 500UW00000k5Y55YAE
More
|
|||||||||
| 2859758 | 09/18/2025 |
RVX |
UNKNOWN MANUFACTURER |
UNK |
Malaise, Pulmonary oedema, Upper respiratory tract infection
Malaise, Pulmonary oedema, Upper respiratory tract infection
|
fluid in the lungs a week after getting the shot; The vaccine made me very sick; upper respiratory I...
fluid in the lungs a week after getting the shot; The vaccine made me very sick; upper respiratory Infection; This serious case was reported by a consumer via interactive digital media and described the occurrence of pulmonary edema in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, 1 week after receiving RSV vaccine, the patient experienced pulmonary edema (Verbatim: fluid in the lungs a week after getting the shot) (serious criteria GSK medically significant), sickness (Verbatim: The vaccine made me very sick) and upper respiratory tract infection (Verbatim: upper respiratory Infection). The outcome of the pulmonary edema, sickness and upper respiratory tract infection were not reported. It was unknown if the reporter considered the pulmonary edema and upper respiratory tract infection to be related to RSV vaccine. The reporter considered the sickness to be related to RSV vaccine. The company considered the pulmonary edema to be unrelated to RSV vaccine. The company considered the sickness to be related to RSV vaccine. It was unknown if the company considered the upper respiratory tract infection to be related to RSV vaccine. Additional Information: GSK receipt date: 04-SEP-2025 This case was reported by a patient via interactive digital media. The vaccine made the patient very sick. The patient got an upper respiratory Infection and fluid in the lungs a week after getting the shot.; Sender's Comments: A case of Pulmonary oedema, 1 week after receiving RSV vaccine, in a patient. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received.
More
|
|||||||||
| 2859759 | 8 | M | TX | 09/18/2025 |
MENB |
NOVARTIS VACCINES AND DIAGNOSTICS |
cd44A |
Product administered to patient of inappropriate age
Product administered to patient of inappropriate age
|
reports that yesterday an 8 year old patient received Bexsero.; This non-serious case was reported b...
reports that yesterday an 8 year old patient received Bexsero.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 8-year-old male patient who received Men B NVS (Bexsero) (batch number cd44A, expiry date 31-AUG-2028) for prophylaxis. On 11-SEP-2025, the patient received Bexsero (intramuscular, left arm). On 11-SEP-2025, an unknown time after receiving Bexsero, the patient experienced inappropriate age at vaccine administration (Verbatim: reports that yesterday an 8 year old patient received Bexsero.). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 12-SEP-2025 The reporter was a medical assistant from a children clinic. The reporter reported that on 11st September 2025 an 8 year old patient received Bexsero which led to inappropriate age at vaccine administration.
More
|
||||||
| 2859760 | 09/18/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Hypoaesthesia, Pain
Hypoaesthesia, Pain
|
Pain for entire month; Foot and toes are numb/ When I try to walk a bit my whole leg goes numb; This...
Pain for entire month; Foot and toes are numb/ When I try to walk a bit my whole leg goes numb; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Herpes Zoster vaccine) for prophylaxis. On an unknown date, the patient received Herpes Zoster vaccine. On an unknown date, an unknown time after receiving Herpes Zoster vaccine, the patient experienced pain (Verbatim: Pain for entire month) and numbness in leg (Verbatim: Foot and toes are numb/ When I try to walk a bit my whole leg goes numb). The outcome of the pain was resolved and the outcome of the numbness in leg was not reported. It was unknown if the reporter considered the pain and numbness in leg to be related to Herpes Zoster vaccine. It was unknown if the company considered the pain and numbness in leg to be related to Herpes Zoster vaccine. Additional Information: GSK Receipt Date: 20-AUG-2025 This case was reported by a patient via interactive digital media. Patient had been in pain for an entire month. Patient's foot and toes were numb. When patient try to walk his/her whole leg goes numb.
More
|
|||||||||
| 2859761 | 09/18/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Incomplete course of vaccination
Incomplete course of vaccination
|
had a shingles shot in 2019 and did not receive the second dose; This non-serious case was reported ...
had a shingles shot in 2019 and did not receive the second dose; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a patient who did not receive Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingles vaccine (1st dose received in 2019). On an unknown date, the patient did not receive the 2nd dose of Shingles vaccine. The patient experienced incomplete course of vaccination (Verbatim: had a shingles shot in 2019 and did not receive the second dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK receipt date: 28-AUG-2025 The patient received the Shingles shot in 2019 and wanted to know if the second dose is required. The patient did not receive the second dose till the time of reporting which led to incomplete course of vaccination.
More
|
|||||||||
| 2859762 | 09/18/2025 |
RVX |
UNKNOWN MANUFACTURER |
UNK |
Chronic obstructive pulmonary disease, Dyspnoea
Chronic obstructive pulmonary disease, Dyspnoea
|
diagnosed after the shot with copd/trouble taking deep breaths; This non-serious case was reported b...
diagnosed after the shot with copd/trouble taking deep breaths; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of chronic obstructive pulmonary disease in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced chronic obstructive pulmonary disease (Verbatim: diagnosed after the shot with copd/trouble taking deep breaths). The patient was treated with salbutamol (Albuterol). The outcome of the chronic obstructive pulmonary disease was not resolved. It was unknown if the reporter considered the chronic obstructive pulmonary disease to be related to RSV vaccine. It was unknown if the company considered the chronic obstructive pulmonary disease to be related to RSV vaccine. Additional Information: GSK Receipt Date: 03-SEP-2025 This case was reported by a patient via interactive digital media. The patient had the RSV shot and thought that he/she still got Respiratory syncytial virus infection (RSV). The patient had trouble taking deep breaths and was diagnosed after the shot with chronic obstructive pulmonary disease (COPD) The patient was now using albuterol nebulizer.
More
|
|||||||||
| 2859763 | 09/18/2025 |
VARZOS VARZOS |
UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER |
UNK UNK |
Herpes zoster, Vaccination failure; Herpes zoster, Vaccination failure
Herpes zoster, Vaccination failure; Herpes zoster, Vaccination failure
|
Suspected vaccination failure; I too got shingles again, after both the vaccines; This serious case...
Suspected vaccination failure; I too got shingles again, after both the vaccines; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: I too got shingles again, after both the vaccines). The outcome of the vaccination failure and shingles were not reported. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine and Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine and Shingles vaccine. Additional Information: GSK receipt date: 05-SEP-2025 This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. This case is linked with US2025AMR115068 reported by same reporter.; Sender's Comments: A case of Vaccination failure, an unknown time after receiving Shingles vaccine and Shingles vaccine, in a patient. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received. US-GSK-US2025AMR115068:Original Case Number : US2025AMR115053
More
|
|||||||||
| 2859764 | 09/18/2025 |
VARZOS VARZOS |
UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER |
UNK UNK |
Herpes zoster, Vaccination failure; Herpes zoster, Vaccination failure
Herpes zoster, Vaccination failure; Herpes zoster, Vaccination failure
|
Suspected vaccination failure; had the two shots, and currently have shingles, have three small dots...
Suspected vaccination failure; had the two shots, and currently have shingles, have three small dots and taking a antiviral, very mild; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: had the two shots, and currently have shingles, have three small dots and taking a antiviral, very mild). The outcome of the vaccination failure was not reported and the outcome of the shingles was not resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine and Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine and Shingles vaccine. Additional Information: GSK receipt date: 08-SEP-2025 This case was reported by a patient via interactive digital media. Patient indicated that shots worked in his/her opinion.; Sender's Comments: A case of Vaccination failure, unknown time after receiving 2nd dose of Shingles vaccine and 1st dose of Shingles vaccine, in a patient. Based on the available information a?possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.
More
|
|||||||||
| 2859765 | F | 09/18/2025 |
VARZOS VARZOS |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
UNK UNK |
Herpes zoster, Vaccination failure; Herpes zoster, Vaccination failure
Herpes zoster, Vaccination failure; Herpes zoster, Vaccination failure
|
Suspected vaccination failure; I got 2 vaccines, and I still got them; This serious case was reporte...
Suspected vaccination failure; I got 2 vaccines, and I still got them; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix and Shingrix, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: I got 2 vaccines, and I still got them). The outcome of the vaccination failure and shingles were not reported. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix. The company considered the vaccination failure and shingles to be unrelated to Shingrix and Shingrix. Additional Information: GSK Receipt Date: 14-SEP-2025 This case was reported by a patient via interactive digital media. Consumer reported that got 2 vaccines and still got them. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting.; Sender's Comments: A case of Vaccination failure and Herpes zoster, less than a day after receiving Shingrix (Dose 1 and Dose 2) in a female patient. Based on the available information a possible causality that the event(s) was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received.
More
|